Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Roche Tecentriq cocktail shows progression-free survival in melanoma patient

      Roche Tecentriq cocktail shows progression-free survival in melanoma patient

      Medical Dialogues Bureau14 Dec 2019 9:20 AM IST
      Roche has an extensive clinical trial development programme for Tecentriq, with more than 50 studies for use in fighting lung, kidney, skin, breast,...
      Sanofi, Biocorp enter partnership to fit SoloStar insulin pens with Mallya technology

      Sanofi, Biocorp enter partnership to fit SoloStar insulin pens with Mallya technology

      Medical Dialogues Bureau14 Dec 2019 9:15 AM IST
      This long-term agreement is the first decision resulting from exclusive negotiations initiated in July 2019. Sanofi and Biocorp are thus fulfilling...
      Aurobindo Pharma arm recalls 59k vials of antipsychotic Fluphenazine Decanoate injection from US

      Aurobindo Pharma arm recalls 59k vials of antipsychotic Fluphenazine Decanoate injection from US

      Medical Dialogues Bureau13 Dec 2019 9:30 AM IST
      Aurobindo Pharma arm AuroMedics Pharma LLC is recalling 59,500 vials of the injection on account of "Discoloration; hazy solution found in one vial...
      Sarepta Therapeutics newest DMD treatment Vyondys 53 gets early USFDA nod

      Sarepta Therapeutics newest DMD treatment Vyondys 53 gets early USFDA nod

      Medical Dialogues Bureau13 Dec 2019 9:30 AM IST
      Sarepta Therapeutics said the new treatment Vyondys 53 is priced at parity to its first DMD drug, Exondys 51, which is priced at about $300,000 per...
      Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M

      Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M

      Medical Dialogues Bureau12 Dec 2019 11:53 AM IST
      Ahmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
      Mumbai-based Eurolife Healthcare to infuse Rs 100 crore for expanding production

      Mumbai-based Eurolife Healthcare to infuse Rs 100 crore for expanding production

      Medical Dialogues Bureau12 Dec 2019 9:30 AM IST
      As a first step, the company has signed up a deal with a Chinese firm for procuring high-speed machines which would enable Eurolife manufactures the...
      AstraZeneca-Daiichi trastuzumab deruxtecan halts cancer for months in first readout

      AstraZeneca-Daiichi trastuzumab deruxtecan halts cancer for months in first readout

      Medical Dialogues Bureau12 Dec 2019 9:05 AM IST
      "This is a totally unprecedented clinical benefit," Jose Baselga, AstraZeneca's head of oncology research and development said of the so-called...
      Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

      Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

      Medical Dialogues Bureau12 Dec 2019 9:00 AM IST
      Edelweiss Tokio Life observed November as Organ Donation Awareness Month, focused on educating, and mobilising support for this cause.New Delhi:...
      Subscription of Piramal debentures by Canadian investor approved by CCI

      Subscription of Piramal debentures by Canadian investor approved by CCI

      Medical Dialogues Bureau11 Dec 2019 12:28 PM IST
      The Competition Commission of India (CCI) in a tweet said it "approves the subscription of CCDs of Piramal Enterprises by CDPQ. Upon conversion, the...
      Sanofi closes research in diabetes, cardiovascular diseases; narrows units to spur profit

      Sanofi closes research in diabetes, cardiovascular diseases; narrows units to spur profit

      Medical Dialogues Bureau11 Dec 2019 9:15 AM IST
      Sanofi, which is due to further detail strategic plans to investors on Tuesday in Cambridge, Massachusetts, said it was targeting new cost savings of...
      SETBACK: Correvio Pharma heart drug Brinavess fails to win USFDA panel backing

      SETBACK: Correvio Pharma heart drug Brinavess fails to win USFDA panel backing

      Medical Dialogues Bureau11 Dec 2019 9:10 AM IST
      The panel voted 11-2 against approving Correvio Pharma's drug, Brinavess, citing serious safety risks, including low blood pressure and irregular...
      Biohaven Pharma Alzheimers treatment Troriluzole to continue late-stage study

      Biohaven Pharma Alzheimers treatment Troriluzole to continue late-stage study

      Medical Dialogues Bureau11 Dec 2019 9:00 AM IST
      Biohaven Pharmaceutical's study of its experimental Alzheimer's treatment, Troriluzole is being led by the Alzheimer's Disease Cooperative Study...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok